Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Core Scientific, Inc. (NASDAQ: CORZ) rose 65% to $0.4125. B. Riley Financial issued an open letter to Core Scientific shareholders and lenders.
Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 58.1% to $0.3711 after declining 4% on Wednesday.
Icosavax, Inc. (NASDAQ: ICVX) shares climbed 42.9% to $12.75. Icosavax shares jumped 112% on Wednesday after the company provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against respiratory syncytial virus
IMV Inc. (NASDAQ: IMV) surged 34.4% to $2.89 after the company announced initial data from the ongoing Phase 2B VITALIZE trial in patients with r/r DLBCL.
Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 22.3% to $3.8898. Clearmind Medicine’s CEO, Dr. Adi Zuloff-Shani, issued a letter to shareholders.
Kintara Therapeutics, Inc. (NASDAQ: KTRA) rose 18.8% to $9.52. Kintara Therapeutics received orphan drug designation for VAL-083 for treatment of diffuse intrinsic pontine glioma.
Lanvin Group Holdings Ltd. (NYSE: LANV) gained 18% to $11.75.
Iterum Therapeutics plc (NASDAQ: ITRM) surged 18% to $1.34 after the company announced issuance of allowance for a U.S. patent covering oral sulopenem.
Troika Media Group, Inc. (NASDAQ: TRKA) gained 17% to $0.12.
Astria Therapeutics, Inc. (NASDAQ: ATXS) rose 15.8% to $12.76. Astria Therapeutics announced preliminary results from the Phase 1a trial of STAR-0215 in healthy subjects.
Steakholder Foods Ltd. (NASDAQ: STKH) rose 15% to $0.89.
Rallybio Corporation (NASDAQ: RLYB) surged 14.1% to $7.20. Rallybio announced publication of data highlighting the ability of HPA-1a-specific antibodies ...
Related tickers: ICVX, HUYA, RLYB, ITRM, INDP, AGYS, ALIT, SRZN, NVAX, AXLA, ATXS, RICK, CRKN, CORZ, SHBI, KTRA, STKH, THRD, ELYS, MLGO, IMV, SIOX, RBLX, GLYC, PBLA, BIMI, WNW, DS, SCPS, NH, VLON, CKPT, TRKA, CVNA, VERV, APRN, MIRO, CMND.
Read Full Article